Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • October
  • Page 28
medwakh-smoking-alters-salivary-proteins-and-cytokines
Posted inBiotechnology

Medwakh Smoking Alters Salivary Proteins and Cytokines

October 18, 2025
In a groundbreaking study, researchers have unveiled the profound impact of Medwakh smoking on salivary proteins and cytokine expression. This…
Read More
esmo-2025:-belzutifan-demonstrates-tumor-reduction-and-symptom-relief-in-patients-with-rare-neuroendocrine-tumors
Posted inBiotechnology

ESMO 2025: Belzutifan Demonstrates Tumor Reduction and Symptom Relief in Patients with Rare Neuroendocrine Tumors

October 18, 2025
In a landmark advancement for the treatment of rare neuroendocrine tumors, researchers have reported groundbreaking results with the oral HIF-2α…
Read More
study:-shugan-jieyu-capsules-boost-zolpidem-for-insomnia
Posted inBiotechnology

Study: Shugan Jieyu Capsules Boost Zolpidem for Insomnia

October 18, 2025
In the quest to find effective treatments for insomnia, particularly when accompanied by depressive symptoms, recent research has shed light…
Read More
new-treatment-combination-enhances-progression-free-survival-in-metastatic-er-positive,-her2-negative-breast-cancer
Posted inBiotechnology

New Treatment Combination Enhances Progression-Free Survival in Metastatic ER-Positive, HER2-Negative Breast Cancer

October 18, 2025
In a landmark advancement for the treatment of metastatic estrogen-receptor-positive (ER-positive), HER-2-negative breast cancer, new clinical trial results reveal a…
Read More
esmo:-tubulis’-next-gen-adc-posts-59%-response-rate,-justifying-investor-interest
Posted inBiotechnology

ESMO: Tubulis’ next-gen ADC posts 59% response rate, justifying investor interest

October 18, 2025
Tubulis’ next-generation antibody-drug conjugate (ADC) has been tied to an overall response rate (ORR) of 59% as the German biotech…
Read More
esmo:-gsk-says-‘stay-tuned’-for-more-adc-data-after-partner-hansoh-posts-49%-response-rate
Posted inBiotechnology

ESMO: GSK says ‘stay tuned’ for more ADC data after partner Hansoh posts 49% response rate

October 18, 2025
GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates (ADCs), but the Big Pharma’s oncology R&D…
Read More
oxidation-and-off-flavors-in-mealworm-oil
Posted inBiotechnology

Oxidation and Off-Flavors in Mealworm Oil

October 18, 2025
In a groundbreaking study that could revolutionize the edible insect oil industry, researchers Choi, Park, and Cho have unveiled intricate…
Read More
understanding-social-skills-and-friendship-in-autism
Posted inBiotechnology

Understanding Social Skills and Friendship in Autism

October 18, 2025
Recent research has brought forth noteworthy insights into the intricate interplay between Theory of Mind, social skills, and friendship quality,…
Read More
next-generation-antibody-drug-conjugates-demonstrate-remarkable-potential-in-early-stage-disease
Posted inBiotechnology

Next-Generation Antibody-Drug Conjugates Demonstrate Remarkable Potential in Early-Stage Disease

October 18, 2025
In a groundbreaking development presented at the ESMO Congress 2025, the oncology field witnesses a transformative leap forward with the…
Read More
clinical-nurse-leadership:-enhancing-unit-care-quality
Posted inBiotechnology

Clinical Nurse Leadership: Enhancing Unit Care Quality

October 18, 2025
In contemporary healthcare systems, the role of clinical nurse leadership is emerging as a pivotal influence on patient outcomes and…
Read More

Posts pagination

Previous page 1 … 26 27 28 29 30 … 71 Next page

Privacy Policy    Terms

Scroll to Top